On the afternoon of July 13th, the Market Supervision and Administration Bureau of Xishan District, Wuxi City carried out a "Safe Use of Equipment and Shared Health" medical device safety promotion activity at Wuxi Yushou Medical Device Co., Ltd. Xu Bo, Director of the Medical Device Supervision Department of Wuxi Market Supervision Bureau, Ye Yingya, Deputy Director of the Medical Device Supervision Department, Xue Ping, Deputy Director of the Municipal Drug Safety Inspection and Testing Center, Hua Sheng, Deputy Director of the District Market Supervision Bureau, Pan Fangfang, Teacher of the Municipal Drug Adverse Reaction Monitoring Center, and Hu Wei, Director of the Drug and Medical Device (Cosmetics) Supervision and Management Department The leaders led by Cai Lei, Deputy Director of Dongbei Tang Branch of the District Market Supervision Bureau, as well as Miao Li, General Manager of Yushou Medical, and heads of various departments of the enterprise, participated in the event.
Experts from the Municipal Adverse Drug Reaction Monitoring Center gave a lecture on knowledge related to adverse event monitoring of medical devices.
At the event, leaders discussed the problems encountered by the enterprise in the process of new medical device research and development, registration and application, change management, and production quality management. The relevant leaders of the Medical Device Supervision and Management Department of the Municipal Bureau consulted the enterprise and proposed relevant guidance plans. The relevant person in charge of the Municipal Drug Safety Inspection and Testing Center listened to the opinions and suggestions of the enterprise on the quality inspection of medical devices and the formulation of quality standards.
Miao Liping, General Manager of Yushou Medical, and Sang Weidong and Zhu Jingjuan, Vice Presidents, expressed sincere gratitude to the leaders for visiting the enterprise and providing precise guidance to Yushou Medical's work. General Manager Miao Liping stated that in the company's production and operation, he will strengthen his awareness of risk signals, establish a solid bottom line thinking, enhance the sense of corporate responsibility, and contribute his modest efforts to the high-quality development of the medical device industry.